Register Login

PRECIGEN, INC. (PGEN)

Tennant Phil 🟡 adjusted position in 81.8K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $7.50 Transaction Date: Aug 23, 2026 | Filing ID: 012871

Full text
Register to leave comments
  • News bot Aug. 25, 2026, 9:26 p.m.

    🔍 Tennant Phil (Executive)

    Company: PRECIGEN, INC. (PGEN)

    Report Date: 2026-08-23

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 84,374
    • Total shares sold: 166,125

    Detailed Transactions and Holdings:

    • Acquired 5,208 shares of Common Stock (Direct)
      Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 144,577.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,585 shares of Common Stock at $7.2 per share (Direct)
      Date: 2026-08-23 | Code: F | equity_swap_involved: 0 | shares_owned_after: 141,992.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 79,166 shares of Common Stock at $1.61 per share (Direct)
      Date: 2026-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 221,158.00 | transaction_form_type: 4
    • Sold 79,166 shares of Common Stock at $7.5 per share (Direct)
      Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 141,992.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 5,208 shares of Restricted Stock Units (Derivative)
      Date: 2026-08-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 57,292.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
    • Sold 79,166 shares of Option to Purchase Common Stock (Right to Buy) at $1.61 per share (Derivative)
      Date: 2026-08-25 | Code: M | Expires: 2034-07-22 | equity_swap_involved: 0 | shares_owned_after: 120,834.00 | transaction_form_type: 4 | Footnotes: F5

    Footnotes:

    • F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
    • F2: Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
    • F3: Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
    • F4: Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
    • F5: The stock options vested 25% on July 22, 2025 and in equal monthly installments for three years thereafter.

Search

News categories